Company Data
Notable Labs Ltd.
Ticker
NTBL
Current Price
$0.38 57.02%
Market Cap
$3.7M
Price Target
Refer to Report
Volume
143.3M
52wk Range
$0.22 - $6.7375
Overview
Vascular Biogenics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumor indications for recurrent glioblastoma, an aggressive form of brain cancer. The company is also engaged in conducting a program targeting anti-inflammatory diseases, based on the use of Lecinoxoid platform technology. The product brands of the company include VTS, Vascular Targeting Systems, Vbl, Vascular Biogenics And Vascular Therapeutics.